Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Randomized phase III trial of single-agent pemetrexed versus carboplatin and pemetrexed in patients with advanced non-small-cell lung cancer and Eastern Cooperative Oncology Group performance status of 2.
Zukin M, Barrios CH, Pereira JR, Ribeiro Rde A, Beato CA, do Nascimento YN, Murad A, Franke FA, Precivale M, Araujo LH, Baldotto CS, Vieira FM, Small IA, Ferreira CG, Lilenbaum RC. Zukin M, et al. Among authors: ribeiro rde a. J Clin Oncol. 2013 Aug 10;31(23):2849-53. doi: 10.1200/JCO.2012.48.1911. Epub 2013 Jun 17. J Clin Oncol. 2013. PMID: 23775961 Clinical Trial.
Large deletions and small insertions and deletions in the factor VIII gene predict unfavorable immune tolerance induction outcome in people with severe hemophilia A and high-responding inhibitors.
Zuccherato LW, Souza RP, Camelo RM, Dias MM, Jardim LL, Santana MAP, Oliveira AG, Lorenzato CS, Cerqueira MH, Franco VKB, Ribeiro RA, Etto LY, Roberti MDRF, Callado FMA, de Cerqueira MAF, Pinto ISS, Garcia AA, Anegawa TH, Neves DCF, Tan DM, Tou RP, Chaves DG, van der Bom J, Rezende SM; HEMFIL Study and the Brazilian Immune Tolerance (BrazIT) Study. Zuccherato LW, et al. Thromb Res. 2024 Oct;242:109115. doi: 10.1016/j.thromres.2024.109115. Epub 2024 Aug 14. Thromb Res. 2024. PMID: 39186847
Changing recombinant factor VIII to plasma-derived factor VIII during immune tolerance induction.
Dias MM, Mesquita Camelo R, de Magalhães LP, Lemos Jardim L, Gonçalves de Oliveira A, Ribeiro RA, Karla Brognoli Franco V, Callado FMRA, Lorenzato CS, Rezende SM; Brazilian Immune Tolerance (BrazIT) Study group. Dias MM, et al. Pediatr Hematol Oncol. 2024;41(1):74-80. doi: 10.1080/08880018.2023.2182853. Epub 2023 Feb 24. Pediatr Hematol Oncol. 2024. PMID: 36825651 No abstract available.
48 results